LARA BLAKE: Open Payments
NPI 1881472371 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 19 payments from 8 companies in 2025. Trend: 2023 $64 · 2024 $339 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $132 |
| United Therapeutics Corporation | 2 | $56 |
| Dexcom, Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $29 |
| ABBVIE INC. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: MOUNJARO, Tyvaso, Dexcom G6 Transmitter, WATCHMAN FLX, Wegovy, CAPLYTA, RINVOQ, VRAYLAR.
Industry payments across MS — which companies pay providers there.
